Cerus Corp. | Mutual Funds
Mutual Funds that own Cerus Corp.
PRIMECAP Odyssey Aggressive Growth Fund
10,300,000
7.7%
2,500,000
0.71%
06/30/2018
ARK Innovation ETF
3,925,237
2.93%
0
2.16%
09/05/2018
Vanguard Total Stock Market Index Fund
3,386,168
2.52%
0
0%
07/31/2018
iShares Russell 2000 ETF
2,710,083
2.02%
-1,446
0.04%
09/06/2018
Vanguard Extended Market Index Fund
1,722,165
1.29%
32,318
0.02%
07/31/2018
iShares Nasdaq Biotechnology ETF
1,506,230
1.12%
-19,698
0.12%
09/06/2018
Harbor Small Cap Growth Opportunities Fund
1,229,471
0.92%
143,116
2.49%
01/31/2018
Wells Fargo Advantage Small Company Growth Portfolio
1,191,212
0.89%
-278,779
0.38%
07/31/2018
SPDR S&P Health Care Equipment ETF
1,102,973
0.82%
0
1.17%
09/06/2018
iShares Russell 2000 Growth ETF
1,098,246
0.82%
0
0.07%
09/06/2018
| Address |
2550 Stanwell Drive
Concord California 94520
United States
|
|
Employees
|
- |
| Website |
http://www.cerus.com |
| Updated |
07/08/2019 |
| Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. It produces blood system for platelets and plasma. It markets its products under the INTERCEPT brand. |
